Abstract
This study aimed to verify the impact of levothyroxine replacement on health-related quality of life (HRQoL) in a Brazilian sample of primary hypothyroidism patients. A cross-sectional study was performed with 2,057 consecutive primary hypothyroidism patients on levothyroxine (LT4) replacement at four referral centers in Brazil (median age = 53; 25th percentile = 43; 75th percentile = 61 years). Patient biochemical data were acquired from medical records, and patients completed a questionnaire on socioeconomic issues and clinical signs and symptoms of hypothyroidism. HRQoL was assessed using the SF-36v2. Patients were divided into three groups according to TSH levels: overtreated (OvT; TSH < 0.4 mU/L), appropriately treated (AT; TSH between 0.4 and 4.0 mU/L), and undertreated (UnT; TSH > 4.0 mU/L). Patients were also analyzed by TSH and FT4 serum levels: overt hyperthyroidism (OHyper; TSH < 0.4 mU/L and FT4 > 1.9 ng/dL), subclinical hyperthyroidism (SHyper; TSH < 0.4 mU/L and FT4 0.8–1.9 ng/dL), subclinical hypothyroidism (SHypo; TSH > 4.0 mU/L and FT4 0.8–1.9 ng/dL), and overt hypothyroidism (OHypo; TSH > 4.0 mU/L and FT4 < 0.8 ng/dL). A total of 14.4 % of patients were OvT, with 13.0 % SHyper and 1.4 % OHyper. The prevalence of UnT was 25.9 %, with 21.5 % SHypo and 4.4 % OHypo. Overtreatment was not associated with HRQoL impairment. UnT patients had worse HRQoL than AT patients, especially for physical and emotional aspects, independent of SHypo or OHypo status. Hypothyroidism undertreatment is associated with poor patient HRQoL. Therefore, adequate LT4 therapy should be given to maintain serum TSH within the reference range.
Similar content being viewed by others
References
J.P. Almandoz, H. Gharib, Hypothyroidism: etiology, diagnosis, and management. Med. Clin. North Am. 96, 203–221 (2012)
D. Khandelwal, N. Tandon, Overt and subclinical hypothyroidism: who to treat and how. Drugs 72, 17–33 (2012)
A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)
M.H. Samuels, K.G. Schuff, N.E. Carlson, P. Carello, J.S. Janowsky, Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 17, 249–258 (2007)
P. Clausen, H. Mersebach, B. Nielsen, B. Feldt-Rasmussen, U. Feldt-Rasmussen, Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin. Endocrinol. (Oxf) 70, 932–937 (2009)
H. Zulewski, B. Müller, P. Exer, A.R. Miserez, J.J. Staub, Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771–776 (1997)
A.T. Dugbartey, Neurocognitive aspects of hypothyroidism. Arch. Intern. Med. 158, 1413–1418 (1998)
D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379, 1142–1154 (2012)
H.J. Baskin, R.H. Cobin, D.S. Duick, H. Gharib, R.B. Guttler, M.M. Kaplan et al., American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Pract. 8, 457–469 (2002)
C.R. Harington, G. Barger, Chemistry of thyroxine–constitution and synthesis of thyroxine. Biochem. J. 21, 169–183 (1927)
O.E. Okosieme, G. Belludi, K. Spittle, R. Kadiyala, J. Richards, Adequacy of thyroid hormone replacement in a general population. QJM 104, 395–401 (2011)
G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)
P. Vigário, P. Teixeira, V. Reuters, C. Almeida, M. Maia, M. Silva et al., Perceived health status of women with overt and subclinical hypothyroidism. Med. Princ. Pract. 18, 317–322 (2009)
C. McMillan, C. Bradley, S. Razvi, J. Weaver, Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. Value Health. 11, 285–294 (2008)
J.E. Ware Jr, SF-36 health survey update. Spine (Phila Pa 1976) 25, 3130–3139 (2000)
L.L. Somwaru, A.M. Arnold, N. Joshi, L.P. Fried, A.R. Cappola, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342–1345 (2009)
R.M. Bagattoli, M. Vaisman, J.S. Lima, L.S. Ward, Estudo de adesão ao tratamento do hipotiroidismo. Arq. Bras. Endocrinol. Metab. 44, 483–487 (2000)
J. John-Kalarickal, G. Pearlman, H.E. Carlson, New medications which decrease levothyroxine absorption. Thyroid 17, 763–765 (2007)
M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43(1), 8–9 (2013)
R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43(1), 154–160 (2013)
P.F. Teixeira, V.S. Reuters, M.M. Ferreira, C.P. Almeida, F.A. Reis, A. Buescu et al., Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl. Res. 151, 224–231 (2008)
B. Demartini, A. Masu, S. Scarone, A.E. Pontiroli, O. Gambini, Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 52, 277–282 (2010)
R. Sharma, T.K. Sharma, G.G. Kaushik, S. Sharma, S.K. Vardey, M. Sinha, Subclinical hypothyroidism and its association with cardiovascular risk factors. Clin. Lab. 57, 719–724 (2011)
F.Y. Tseng, W.Y. Lin, C.C. Lin, L.T. Lee, T.C. Li, P.K. Sung et al., Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J. Am. Coll. Cardiol. 60, 730–737 (2012)
B. Biondi, Natural history, diagnosis and management of subclinical thyroid dysfunction. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 431–446 (2012)
S. Gulseren, L. Gulseren, Z. Hekimsoy, P. Cetinay, C. Ozen, B. Tokatlioglu, Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch. Med. Res. 37, 133–139 (2006)
V.S. Reuters, A. Buescu, F.A. Reis, C.P. Almeida, P.F. Teixeira, A.J. Costa et al., Clinical and muscular evaluation in patients with subclinical hypothyroidism. Arq. Bras. Endocrinol. Metabol. 50, 523–531 (2006)
V.S. Reuters, C.P. Almeida, P.F. Teixeira, P.S. Vigário, M.M. Ferreira, C.L. Castro et al., Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq. Bras. Endocrinol. Metabol. 56, 128–136 (2012)
G.P. Bianchi, V. Zaccheroni, E. Solaroli, F. Vescini, R. Cerutti, M. Zoli et al., Health-related quality of life in patients with thyroid disorders. Qual. Life Res. 13, 45–54 (2004)
Acknowledgments
We would like to thank Merck Brazil for financial support.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vigário, P.d.S., Vaisman, F., Coeli, C.M. et al. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life–a Brazilian multicentre study. Endocrine 44, 434–440 (2013). https://doi.org/10.1007/s12020-013-9886-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9886-1